RxDoctor Payments Data

Mehrzad Seraji, MD

Psychiatry · Saint Louis, MONPI 1942539085

Payments from drug & device makers

$3,046in general payments, 2019–2025

Across 160 payments — averaging $19.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$408
  • Johnson & Johnson$345
  • Teva Pharmaceuticals USA, Inc.$311
  • Alkermes, Inc.$236
  • Neurocrine Biosciences, Inc.$225
  • Otsuka America Pharmaceutical, Inc.$157
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$2,92696%
  • Education$1204%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,046 in reported general payments places this provider in the 80th percentile of 680 psychiatry providers in Missouri.

See all psychiatry providers in Missouri

Medicare billing

Part B allowed, 2024
$56,391
Medicare patients
128
Services billed
479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate35$311,977
RexultiBrexpiprazole17$37,410
VraylarCariprazine Hcl25$35,178
TrintellixVortioxetine Hydrobromide23$15,584
Lurasidone Hcl55$11,561
Quetiapine Fumarate156$9,885
Bupropion XlBupropion Hcl302$4,961
Vilazodone Hcl52$4,182
Duloxetine Hcl311$4,106
Lamotrigine316$3,451
Desvenlafaxine Succinate ErDesvenlafaxine Succinate63$3,232
Aripiprazole101$2,649
Clozapine11$2,530
Buspirone Hcl177$2,287
Divalproex Sodium ErDivalproex Sodium25$2,252

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$225$311,97735 claims
Otsuka America Pharmaceutical, Inc.Rexulti$157$37,41017 claims
AbbVieVraylar$408$35,17825 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$147$15,58423 claims
Almatica Pharma LLCSertraline Hcl$57$1,047209 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 680 psychiatry providers in Missouri.

Other psychiatry in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →